MedTrace Logo

DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation

NCT00487279 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2019-02-05

Study results available
· View outcomes & findings →

Summary

This trial is a prospective, multi-center, randomized study of patients with coronary artery disease (CAD) and mild to moderate left ventricular (LV) dysfunction. The primary objective of this study is to test the hypothesis that Implantable Cardioverter Defibrillator (ICD) therapy in combination with medical therapy in patients with an infarct size greater than or equal to 10% of the left ventricular mass improves long term survival compared to medical therapy alone. In addition to the 2-arm randomized trial, the study will also include a non-investigational registry of non-randomized patients.

Conditions

Interventions

DEVICE

Defibrillator

ICD(Implantable Cardioverter Defibrillator)

OTHER

Control

No Intervention

Sponsors & Collaborators

Principal Investigators

  • Alan Kadish, MD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2010-12-31
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00487279 on ClinicalTrials.gov